Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Jesús Molinar-DíazAdvanced Materials Research Group, Faculty of Engineering, University of Nottingham, Nottingham NG7 2RD, UK.ORCID 0000-0002-5551-8769
Andi ArjunaAdvanced Materials Research Group, Faculty of Engineering, University of Nottingham, Nottingham NG7 2RD, UK.
Nichola AbrehartNottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.ORCID 0000-0003-2456-3222
Alison McLellanSchool of Chemistry, University of Nottingham, Nottingham NG7 2RD, UK.
Roy HarrisResearch Design Service East Midlands, Queen's Medical Centre, Nottingham NG7 2UH, UK.
Md Towhidul IslamAdvanced Materials Research Group, Faculty of Engineering, University of Nottingham, Nottingham NG7 2RD, UK.ORCID 0000-0001-7530-8315
Ahlam AlzaidiSchool of Life Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, UK.ORCID 0009-0004-8807-4895
Chris R BradleySir Peter Mansfield Imaging Centre, School of Medicine, University of Nottingham, Nottingham NG7 2QX, UK.ORCID 0000-0002-2174-2279
Charlotte GidmanSchool of Chemistry, University of Nottingham, Nottingham NG7 2RD, UK.
Malcolm J W PriorSir Peter Mansfield Imaging Centre, School of Medicine, University of Nottingham, Nottingham NG7 2QX, UK.
Jeremy TitmanSchool of Chemistry, University of Nottingham, Nottingham NG7 2RD, UK.
Nicholas P BlockleySchool of Life Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, UK.
Peter HarveySchool of Chemistry, University of Nottingham, Nottingham NG7 2RD, UK.
Luca MarcianiNottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.ORCID 0000-0001-9092-4300
Ifty AhmedAdvanced Materials Research Group, Faculty of Engineering, University of Nottingham, Nottingham NG7 2RD, UK.ORCID 0000-0001-7868-3698
Funding
Academy of Medical Sciences Springboard Award SBF007\100120EPSRC Future Composites Manufacturing Research Hub EP/P006701/1National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre
6 · The paper itself
Abstract
In this research, resorbable phosphate-based glass (PBG) compositions were developed using varying modifier oxides including iron (Fe
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Development of Resorbable Phosphate-Based Glass Microspheres as MRI Contrast Media Agents. · full record | OpenQuestion